首页 | 本学科首页   官方微博 | 高级检索  
     

人表皮生长因子受体-2及雌激素受体与乳腺癌的关系
引用本文:郭奕阳,张金艳. 人表皮生长因子受体-2及雌激素受体与乳腺癌的关系[J]. 现代肿瘤医学, 2016, 0(17): 2802-2805. DOI: 10.3969/j.issn.1672-4992.2016.17.039
作者姓名:郭奕阳  张金艳
作者单位:河北医科大学第四医院检验科,河北 石家庄 050011
基金项目:河北省卫生厅科研基金项目(编号ZL20140109)
摘    要:乳腺癌与人表皮生长因子受体-2及雌激素受体关系密切,这两种受体也是乳腺癌的分类标准和治疗靶点。在大多数乳腺癌患者中,人表皮生长因子受体-2信号途径和雌激素受体信号途径参与了细胞的增生存活过程。而且在乳腺癌病例中,人表皮生长因子受体-2和雌激素受体呈现出一定程度的负相关。这说明这两种受体活化后有一些联系。本文简要综述了人表皮生长因子受体-2和雌激素受体的联系以及这种联系在乳腺癌治疗中的意义。

关 键 词:乳腺癌  人表皮生长因子受体-2  雌激素受体

The relation of breast cancer with human epidermal growth factor receptor 2 and estrogen receptor
Guo Yiyang,Zhang Jinyan. The relation of breast cancer with human epidermal growth factor receptor 2 and estrogen receptor[J]. Journal of Modern Oncology, 2016, 0(17): 2802-2805. DOI: 10.3969/j.issn.1672-4992.2016.17.039
Authors:Guo Yiyang  Zhang Jinyan
Affiliation:Department of Laboratory Medicine,the Fourth Hospital of Hebei Medical University,Hebei Shijiazhuang 050011,China.
Abstract:Human epidermal growth factor receptor 2 and estrogen receptor were found in breast cancer.Breast canc-er was classified by human epidermal growth factor receptor 2 and estrogen receptor.The estrogen receptor and the hu-man epidermal growth factor receptor 2 signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancer.There was an inverse correlation between the human epidermal growth factor re-ceptor 2 and the estrogen receptor in many breast cancer cases.There was a correlation between the human epidermal growth factor receptor 2 signaling pathways and the estrogen receptor signaling pathways.We reviewed the correlation and the clinical use of the correlation.
Keywords:breast cancer  human epidermal growth factor receptor 2  estrogen receptor
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号